Musso Alan A

CIK 00012958304 companiesWINSTON-SALEM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001295830

Recent Transactions

50 trades

Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2025-07-23+17,500→ 17,500 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2025-01-24+285,000→ 285,000 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2024-12-02+35,000→ 35,000 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2024-08-20+2,725→ 2,725 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2024-01-26+100,000→ 100,000 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2024-01-17+61,822→ 61,822 total
Award
Rein Therapeutics, Inc.$RNTX
Stock Option (right to buy)
2023-10-31+5,450→ 5,450 total
Award
Fulcrum Therapeutics, Inc.$FULC
Stock Option (right to buy)
2023-08-07+432,800→ 432,800 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2018-07-02+52,500→ 52,500 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2018-05-25$7.97/sh−6,206→ 26,548 total
Tax Payment
BELLICUM PHARMACEUTICALS, INC
Common Stock
2018-01-03$9.79/sh−706→ 32,754 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2018-01-03−1,875→ 5,625 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2018-01-03+1,875→ 33,460 total
Award
BELLICUM PHARMACEUTICALS, INC
Employee Stock Option (right to buy)
2018-01-02+22,500→ 22,500 total
Award
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2018-01-02+12,500→ 12,500 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2017-12-11$9.33/sh−17,117→ 31,585 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2017-11-27$9.89/sh+6,206→ 48,702 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2017-07-03+31,500→ 31,500 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2017-05-25$12.24/sh−6,311→ 54,908 total
Award
BELLICUM PHARMACEUTICALS, INC
Employee Stock Option (right to buy)
2017-01-03+13,500→ 13,500 total
Award
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2017-01-03+7,500→ 7,500 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-11-28$19.84/sh−600→ 60,548 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-11-28$19.23/sh−22,427→ 61,148 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-11-25$20.48/sh−6,273→ 83,575 total
Award
BELLICUM PHARMACEUTICALS, INC
Employee Stock Option (right to buy)
2016-01-04+60,000→ 60,000 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-11-24$22.34/sh−29,300→ 88,742 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2015-02-24+60,000→ 60,000 total
Award
BELLICUM PHARMACEUTICALS, INC
Employee Stock Option (right to buy)
2014-12-18+117,647→ 117,647 total
Award
BELLICUM PHARMACEUTICALS, INC
Common Stock
2014-12-18+117,647→ 117,647 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2014-10-17+55,000→ 57,799 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2014-01-23+55,000→ 55,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2013-01-17+65,000→ 65,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2012-05-04+100,000→ 100,000 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-06-07−16,368→ 49,107 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-06-07−11,627→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-06-07$5.63/sh+2,880→ 17,306 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-06-07$5.55/sh+16,368→ 33,674 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-06-07$21.80/sh−30,875→ 2,799 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-06-07−2,880→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2011-06-07$5.10/sh+11,627→ 14,426 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2011-03-29+50,000→ 50,000 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-22$26.47/sh−4,881→ 2,799 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-22−4,881→ 11,627 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-22$5.10/sh+4,881→ 7,680 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-21−6,746→ 16,508 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-12-21−8,789→ 0 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-21$5.10/sh+15,535→ 18,334 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-12-21$26.61/sh−15,535→ 2,799 total
Exercise/Conversion
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2010-10-28−1,500→ 36,094 total
Sale
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2010-10-28$24.60/sh−1,500→ 2,799 total

Musso Alan A

Recent Transactions

Companies

Recent Filings

Address